Biotrial’s preclinical pharmacology unit provides a wide range of services to support the drug discovery and development process, from in vitro to in vivo pharmacology studies. Our team of experienced scientists has over 30 years of experience in designing and conducting preclinical studies, and we are committed to providing our clients with the highest quality data and support.
Biotrial’s drug efficacy services assess the therapeutic potential of your drug candidates in a variety of disease models. We use our expertise in pharmacology, biochemistry, and molecular biology to design and conduct studies that measure the effects of your drug on disease-related biomarkers and endpoints.
In vitro assays: We screen your drug candidates against a variety of targets and cell lines to identify those with the most promising activity.
In vivo models: We test your drug candidates in a variety of animal models of disease to assess their efficacy and safety.
Translational studies: We bridge the gap between preclinical and clinical development by conducting studies that predict the efficacy and safety of your drug candidates in humans.
Biotrial’s drug safety services assess the potential of your drug candidates in a variety of animal models. We use our expertise in pharmacology, and pathology to design and conduct studies that measure the effects of your drug on major organ systems and physiological functions.
Safety pharmacology studies: We assess the potential effects of your drug candidates on cardiovascular, respiratory, central nervous system, and other organ systems.
Safety De-risking: to reduce the risks, time delays and costs of advancing basic research compounds
Biotrial’s pharmacokinetic services assess the absorption, distribution, metabolism, and excretion of your drug candidates. We use our expertise in analytical chemistry and biostatistics to design and conduct studies that measure the concentration of your drug in blood and tissues over time.
Preclinical PK studies: We assess the pharmacokinetics of our sponsor’s drug candidates in rodents and non-rodents to determine their optimal dosing and formulation.
Pharmacokinetic modeling and simulation: We use pharmacokinetic data to develop models that predict the concentration of your drug in blood and tissues over time.
In Vivo Pharmacokinetics
Analysis methods: including Non-compartmental analysis (NCA), Compartmental analysis (CA) for mechanism understanding (e.g.: bi-phasic profiles), Pharmacokinetic-Pharmacodynamic analysis, and Population pharmacokinetics
Safety De-risking: to reduce the risks, time delays, and costs of advancing basic research compounds
Biotrial’s model development services help you to select and develop the best animal models for your drug discovery and development program. We use our expertise in disease modeling, and pharmacology to design and develop models that recapitulate the key features of your target disease and can be used to assess the efficacy and safety of your drug candidates.
Disease modeling: We develop new animal models of disease that can be used to assess the efficacy and safety of your drug candidates.
Model validation: We validate existing animal models of disease to ensure that they are suitable for your drug discovery and development program.
Model selection: We help you select the best animal models for your drug discovery and development program based on your specific needs.
Our 2,500 m²/ 27,000 sq ft preclinical labs are state-of-the-art, AAALAC-accredited facilities that house multiple species. We place a strong emphasis on animal welfare and use the latest technologies to ensure that our studies are conducted in a humane and ethical manner.
The preclinical development of a drug involves a complex network of interconnected studies. Engaging a preclinical research partner who can oversee and conduct most, if not all, of the necessary preclinical research, will simplify the contracting process, streamline assay transfer, and facilitate smooth transitions between different sets of studies and activities.
It is advisable to collaborate with a preclinical research partner who possesses a rich and diverse scientific knowledge base, as this will contribute to the efficient and successful progression of a drug development program. Such partners are well-versed in the nuances of the target and potential safety concerns, which is crucial for designing appropriate preclinical studies. They can also anticipate the specific areas of focus for regulatory authorities. Furthermore, their experience and expertise become invaluable when unforeseen challenges arise, typically a matter of “when” rather than “if.” A proficient CRO partner can swiftly assess such situations and propose rational solutions.
Oncology, EEG/ECG, Imaging, Neurology, Haemodynamics, and more…
At Biotrial, we work with our clinical colleagues and the neighboring hospital
A high degree of collaboration between project managers and study monitors
Our extensive network and experience will aid you in designing the best experimental model for your studies
Biotrial’s team is composed of highly skilled and experienced professionals with a strong commitment to quality. Our zootechnicians, lab technicians, study directors, lab managers, and veterinarians are each committed to providing our clients with the highest quality preclinical services. We are confident that our team has the expertise and experience necessary to help you achieve your research goals.
Listen to one of our preclinical Product Managers introduce preclinical services at Biotrial.